Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Harris Corporation (NYSE:HRS)?

Is Harris Corporation (NYSE:HRS) a bargain? The best stock pickers are in an optimistic mood. The number of bullish hedge fund positions increased by 3 lately.

To the average investor, there are dozens of metrics investors can use to analyze stocks. Some of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite investment managers can trounce the S&P 500 by a very impressive amount (see just how much).

Harris Corporation (NYSE:HRS)

Just as integral, bullish insider trading sentiment is a second way to parse down the marketplace. There are a number of incentives for a bullish insider to drop shares of his or her company, but just one, very obvious reason why they would buy. Several academic studies have demonstrated the market-beating potential of this strategy if investors know where to look (learn more here).

With all of this in mind, we’re going to take a gander at the recent action regarding Harris Corporation (NYSE:HRS).

How have hedgies been trading Harris Corporation (NYSE:HRS)?

At year’s end, a total of 21 of the hedge funds we track held long positions in this stock, a change of 17% from the previous quarter. With hedgies’ capital changing hands, there exists a few notable hedge fund managers who were increasing their holdings substantially.

When looking at the hedgies we track, Michael Price’s MFP Investors had the most valuable position in Harris Corporation (NYSE:HRS), worth close to $16 million, accounting for 2.3% of its total 13F portfolio. On MFP Investors’s heels is GMT Capital, managed by Thomas E. Claugus, which held a $12 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Remaining hedge funds that are bullish include Debra Fine’s Fine Capital Partners, Amy Minella’s Cardinal Capital and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

Consequently, some big names were breaking ground themselves. Arrowstreet Capital, managed by Peter Rathjens, Bruce Clarke and John Campbell, established the most valuable position in Harris Corporation (NYSE:HRS). Arrowstreet Capital had 7 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also initiated a $6 million position during the quarter. The other funds with new positions in the stock are Cliff Asness’s AQR Capital Management, Israel Englander’s Millennium Management, and Douglas W. Case’s Advanced Investment Partners.

What do corporate executives and insiders think about Harris Corporation (NYSE:HRS)?

Insider trading activity, especially when it’s bullish, is at its handiest when the company in question has experienced transactions within the past six months. Over the last 180-day time period, Harris Corporation (NYSE:HRS) has experienced zero unique insiders buying, and 7 insider sales (see the details of insider trades here).

With the results shown by our strategies, retail investors must always keep an eye on hedge fund and insider trading activity, and Harris Corporation (NYSE:HRS) is an important part of this process.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!